John Sondek

PhD, Pharmacology, UNC-Chapel Hill, Molecular Therapeutics

PhD
Professor, Pharmacology
Biochemistry and Biophysics
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

Our laboratory studies signal transduction systems controlled by heterotrimeric G proteins as well as Ras-related GTPases. The superfamily of GTPases control numerous signaling cascades based upon the regulated binding, hydrolysis, and exchange of guanine nucleotides; GTPases bound to GTP are active in downstream signaling while those bound to GDP are inactive. Mutant GTPases with abnormal GDP/GTP cycling are implicated in numerous human diseases, including cancer. It is our desire to better understand the regulation of heterotrimeric G proteins and Ras-related GTPases at the molecular level with the ultimate goal of using this information to design therapies to correct abnormal signaling mediated by these proteins and thereby treat associated pathologies.

Reach NC Profile

Find publications on Pubmed

John Sondek